Tulane University Study Uses AI to Detect Colorectal Cancer

A Tulane University researcher found that artificial intelligence (AI) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study in the journal Nature Communications.

The study, which was conducted by researchers from Tulane, Central South University in China, the University of Oklahoma Health Sciences Center, Temple University, and Florida State University, was designed to test whether AI could be a tool to help pathologists keep pace with the rising demand for their services.

Pathologists evaluate and label thousands of histopathology images on a regular basis to tell whether someone has cancer. But their average workload has increased significantly and can sometimes cause unintended misdiagnoses due to fatigue.

"Even though a lot of their work is repetitive, most pathologists are extremely busy because there's a huge demand for what they do but there’s a global shortage of qualified pathologists, especially in many developing countries" said Dr. Hong-Wen Deng, professor and director of the Tulane Center of Biomedical Informatics and Genomics at Tulane University School of Medicine. "This study is revolutionary because we successfully leveraged artificial intelligence to identify and diagnose colorectal cancer in a cost-effective way, which could ultimately reduce the workload of pathologists."

To conduct the study, Deng and his team collected over 13,000 images of colorectal cancer from 8,803 subjects and 13 independent cancer centers in China, Germany and the United States. Using the images, which were randomly selected by technicians, they built a machine assisted pathological recognition program that allows a computer to recognize images that show colorectal cancer, one of the most common causes of cancer related deaths in Europe and America.

"The challenges of this study stemmed from complex large image sizes, complex shapes, textures, and histological changes in nuclear staining," Deng said. "But ultimately the study revealed that when we used AI to diagnose colorectal cancer, the performance is shown comparable to and even better in many cases than real pathologists."

The area under the receiver operating characteristic (ROC) curve or AUC is the performance measurement tool that Deng and his team used to determine the success of the study. After comparing the computer’s results with the work of highly experienced pathologists who interpreted data manually, the study found that the average pathologist scored at .969 for accurately identifying colorectal cancer manually. The average score for the machine-assisted AI computer program was .98, which is comparable if not more accurate.

Using artificial intelligence to identify cancer is an emerging technology and hasn’t yet been widely accepted. Deng’s hope is that the study will lead to more pathologists using prescreening technology in the future to make quicker diagnoses.

"It's still in the research phase and we haven't commercialized it yet because we need to make it more user friendly and test and implement in more clinical settings. But as we develop it further, hopefully it can also be used for different types of cancer in the future. Using AI to diagnose cancer can expedite the whole process and will save a lot of time for both patients and clinicians."

Yu G, Sun K, Xu C, Shi XH, Wu C, Xie T, Meng RQ, Meng XH, Wang KS, Xiao HM, Deng HW.
Accurate recognition of colorectal cancer with semi-supervised deep learning on pathological images.
Nat Commun. 2021 Nov 2;12(1):6311. doi: 10.1038/s41467-021-26643-8

Most Popular Now

Artificial Intelligence in Healthcare Re…

This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of...

Giving AI Penalties to Get Better Diagno…

Anyone waiting for the results of a medical test knows the anxious question: 'Will my life change completely when I know?' And the relief if you test negative. Nowadays, Artificial Intelligence...

First-of-its-Kind Healthcare Communicati…

A web and mobile app-based start-up launched during the COVID-19 pandemic to help UK healthcare professionals communicate with patients has signed its first commercial agreement with a hospital trust...

New App Helps Parents Identify Treatable…

A ground-breaking new, mobile phone app, 'GrowthMonitor' places the accurate measurement of children's height in the hands of parents and carers. Preliminary data to be presented at the Society for...

DMEA Call for Papers: Digital Health in …

26 - 28 April 2022, Berlin, Germany. Health meets digitalisation. From 26 to 28 April 2022 DMEA - Connecting Digital Health, the leading platform for health IT, is opening its doors...

Health Meets IT: DMEA Newcomer Award Inv…

26 - 28 April 2022, Berlin, Germany. Digitalisation of our healthcare sector must be stepped up - the experience of recent months has shown that. It is why new ideas on...

Bittium Exhibits its High-Tech Medical T…

Bittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It...

Development of AI Technology for Produci…

Transcranial focused ultrasound can be used to treat degenerative movement disorders, intractable pain, and mental disorders by delivering ultrasound energy to a specific area of the brain without opening the...

Siemens Healthineers and UCSF Create Fir…

Siemens Healthineers and UC San Francisco have formed a research and innovation-driven collaboration to make radiological imaging greener, while improving access to and quality of radiological imaging in Northern California...

Tulane University Study Uses AI to Detec…

A Tulane University researcher found that artificial intelligence (AI) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study...

Dedalus Acquires Swiftqueue to Support P…

Dedalus Group ("Dedalus"), a leading international healthcare software solutions provider, has announced to have completed the acquisition of 100% of Swiftqueue Technologies Ltd a fast-growing cloud-native appointment and scheduling solution...

FDA Authorizes Marketing of Virtual Real…

The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with...